UCSD Cancer Center

In 1977, the National Cancer Institute designated UCSD a Specialized Cancer Center. Two years later, it was granted NCI designation as a Clinical Cancer Center. It is currently composed of 171 Members drawn from 18 University departments and has a total peer-review funded income of $43.5 Million per annum (Direct Cost), of which $13.1 Million per annum is awarded by the NCI.  An additional $11.1 Million per annum comes from non-peer reviewed sources. The Center conducts its collective research operations in over 119,000 sq ft of space, 47,000 sq ft of which are under the control of the Cancer Center Director. Center membership includes: One Nobel Laureate, five Members of the National Academy of Sciences, two Members of the National Institute for Environmental Health Sciences, one member of the Advisory Council of the NCI, and the President of the American Association of Cancer Research. The Center has seven Research Programs which reflect its scientific strengths and evolving interests, namely Cancer Biology, Cancer Genetics, Cancer Pharmacology, Cancer Prevention and Control, Palliative Care, Translational Oncology and Viral Malignancy. Translational oncology embodies the central philosophy of UCSD Cancer Center, which places the highest priority and emphasis on converting the discoveries from high quality research into tangible improvements in prevention, diagnosis, treatment and amelioration of discomfort for the benefit of the community.

Cancer Center website